These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 36107175)

  • 1. [The combination of recurrent otitis media and adenotomy in early childhood as diagnostic marker of mucopolysaccharidosis type II (Hunter syndrome)].
    Kuznetsova NE; Kuznetsova TB
    Vestn Otorinolaringol; 2022; 87(4):19-22. PubMed ID: 36107175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Otorhinolaryngological manifestations in 61 patients with mucopolysaccharidosis.
    Murgasova L; Jurovcik M; Jesina P; Malinova V; Bloomfield M; Zeman J; Magner M
    Int J Pediatr Otorhinolaryngol; 2020 Aug; 135():110137. PubMed ID: 32502916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of surgical history in diagnosing mucopolysaccharidosis type II (Hunter syndrome): data from the Hunter Outcome Survey.
    Mendelsohn NJ; Harmatz P; Bodamer O; Burton BK; Giugliani R; Jones SA; Lampe C; Malm G; Steiner RD; Parini R;
    Genet Med; 2010 Dec; 12(12):816-22. PubMed ID: 21045710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First experience of enzyme replacement therapy with idursulfase in Spanish patients with Hunter syndrome under 5 years of age: case observations from the Hunter Outcome Survey (HOS).
    Alcalde-Martín C; Muro-Tudelilla JM; Cancho-Candela R; Gutiérrez-Solana LG; Pintos-Morell G; Martí-Herrero M; Munguira-Aguado P; Galán-Gómez E
    Eur J Med Genet; 2010; 53(6):371-7. PubMed ID: 20709629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy.
    Wraith JE; Scarpa M; Beck M; Bodamer OA; De Meirleir L; Guffon N; Meldgaard Lund A; Malm G; Van der Ploeg AT; Zeman J
    Eur J Pediatr; 2008 Mar; 167(3):267-77. PubMed ID: 18038146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recognition and diagnosis of mucopolysaccharidosis II (Hunter syndrome).
    Martin R; Beck M; Eng C; Giugliani R; Harmatz P; Muñoz V; Muenzer J
    Pediatrics; 2008 Feb; 121(2):e377-86. PubMed ID: 18245410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term enzyme replacement therapy in a severe case of mucopolysaccharidosis type II (Hunter syndrome).
    Papadia F; Lozupone MS; Gaeta A; Capodiferro D; Lacalendola G
    Eur Rev Med Pharmacol Sci; 2011 Mar; 15(3):253-8. PubMed ID: 21528770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucopolysaccharidosis type II with inguinal hernia.
    Rayamajhi A; Pokharel PJ; Chapagain R; Rayamajhi AK
    J Nepal Health Res Counc; 2013 Sep; 11(25):293-5. PubMed ID: 24908534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective analysis of the clinical manifestations and survival of Korean patients with mucopolysaccharidosis type II: emphasis on the cardiovascular complication and mortality cases.
    Sohn YB; Choi EW; Kim SJ; Park SW; Kim SH; Cho SY; Jeong SI; Huh J; Kang IS; Lee HJ; Paik KH; Jin DK
    Am J Med Genet A; 2012 Jan; 158A(1):90-6. PubMed ID: 22105882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasal Polyposis in mucopolysaccharidosis type II.
    Kabekkodu S; Sreedharan S; Gupta K; Murali N
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33674293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of mucopolysaccharidoses by analyses of the excreted sulfated mucopolysaccharides.
    Cohen DM; Mourão PA; Dietrich CP
    Clin Chim Acta; 1977 Nov; 80(3):555-62. PubMed ID: 144036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hunter syndrome follow-up after 1 year of enzyme-replacement therapy.
    Puiu M; Chirita-Emandi A; Dumitriu S; Arghirescu S
    BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23307460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute airway obstruction in Hunter syndrome.
    Yoskovitch A; Tewfik TL; Brouillette RT; Schloss MD; Der Kaloustian VM
    Int J Pediatr Otorhinolaryngol; 1998 Aug; 44(3):273-8. PubMed ID: 9780074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome).
    da Silva EM; Strufaldi MW; Andriolo RB; Silva LA
    Cochrane Database Syst Rev; 2011 Nov; (11):CD008185. PubMed ID: 22071845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme replacement therapy with idursulfase for mucopolysaccharidosis type II (Hunter syndrome).
    da Silva EM; Strufaldi MW; Andriolo RB; Silva LA
    Cochrane Database Syst Rev; 2014 Jan; (1):CD008185. PubMed ID: 24399699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case report: a rare case of Hunter syndrome (type II mucopolysaccharidosis) in a girl.
    Semyachkina AN; Voskoboeva EY; Zakharova EY; Nikolaeva EA; Kanivets IV; Kolotii AD; Baydakova GV; Kharabadze MN; Kuramagomedova RG; Melnikova NV
    BMC Med Genet; 2019 May; 20(1):66. PubMed ID: 31046699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mutational spectrum of hunter syndrome reveals correlation between biochemical and clinical profiles in Tunisian patients.
    Chkioua L; Grissa O; Leban N; Gribaa M; Boudabous H; Turkia HB; Ferchichi S; Tebib N; Laradi S
    BMC Med Genet; 2020 May; 21(1):111. PubMed ID: 32448126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzyme replacement therapy with idursulfase in patients with mucopolysaccharidosis type II.
    Wraith JE
    Acta Paediatr; 2008 Apr; 97(457):76-8. PubMed ID: 18339193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucopolysaccharidosis type II (Hunter syndrome): Clinical and biochemical aspects of the disease and approaches to its diagnosis and treatment.
    Mohamed S; He QQ; Singh AA; Ferro V
    Adv Carbohydr Chem Biochem; 2020; 77():71-117. PubMed ID: 33004112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of otolaryngological manifestations in mucopolysaccharidoses: our experience.
    Mesolella M; Cimmino M; Cantone E; Marino A; Cozzolino M; Della Casa R; Parenti G; Iengo M
    Acta Otorhinolaryngol Ital; 2013 Aug; 33(4):267-72. PubMed ID: 24043915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.